Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
| Autor: | Morschhauser, F. *, Marlton, P., Vitolo, U., Lindén, O., Seymour, J.F., Crump, M., Coiffier, B., Foà, R., Wassner, E., Burger, H.-U., Brennan, B., Mendila, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2010 21(9):1870-1876 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|